Literature DB >> 21866955

Snooker: a structure-based pharmacophore generation tool applied to class A GPCRs.

Marijn P A Sanders1, Stefan Verhoeven, Chris de Graaf, Luc Roumen, Bas Vroling, Sander B Nabuurs, Jacob de Vlieg, Jan P G Klomp.   

Abstract

G-protein coupled receptors (GPCRs) are important drug targets for various diseases and of major interest to pharmaceutical companies. The function of individual members of this protein family can be modulated by the binding of small molecules at the extracellular side of the structurally conserved transmembrane (TM) domain. Here, we present Snooker, a structure-based approach to generate pharmacophore hypotheses for compounds binding to this extracellular side of the TM domain. Snooker does not require knowledge of ligands, is therefore suitable for apo-proteins, and can be applied to all receptors of the GPCR protein family. The method comprises the construction of a homology model of the TM domains and prioritization of residues on the probability of being ligand binding. Subsequently, protein properties are converted to ligand space, and pharmacophore features are generated at positions where protein ligand interactions are likely. Using this semiautomated knowledge-driven bioinformatics approach we have created pharmacophore hypotheses for 15 different GPCRs from several different subfamilies. For the beta-2-adrenergic receptor we show that ligand poses predicted by Snooker pharmacophore hypotheses reproduce literature supported binding modes for ∼75% of compounds fulfilling pharmacophore constraints. All 15 pharmacophore hypotheses represent interactions with essential residues for ligand binding as observed in mutagenesis experiments and compound selections based on these hypotheses are shown to be target specific. For 8 out of 15 targets enrichment factors above 10-fold are observed in the top 0.5% ranked compounds in a virtual screen. Additionally, prospectively predicted ligand binding poses in the human dopamine D3 receptor based on Snooker pharmacophores were ranked among the best models in the community wide GPCR dock 2010.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866955     DOI: 10.1021/ci200088d

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  12 in total

1.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

2.  Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes.

Authors:  Sivakumar Prasanth Kumar
Journal:  J Mol Model       Date:  2018-09-15       Impact factor: 1.810

3.  Structure based virtual screening of natural product molecules as glycosidase inhibitors.

Authors:  N S Hari Narayana Moorthy; Natércia F Brás; Maria J Ramos; Pedro A Fernandes
Journal:  In Silico Pharmacol       Date:  2021-10-16

4.  Choosing the Optimal Rigid Receptor for Docking and Scoring in the CSAR 2013/2014 Experiment.

Authors:  Matthew P Baumgartner; Carlos J Camacho
Journal:  J Chem Inf Model       Date:  2015-08-07       Impact factor: 4.956

Review 5.  Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery.

Authors:  Valère Lounnas; Tina Ritschel; Jan Kelder; Ross McGuire; Robert P Bywater; Nicolas Foloppe
Journal:  Comput Struct Biotechnol J       Date:  2013-04-02       Impact factor: 7.271

6.  Snooker structure-based pharmacophore model explains differences in agonist and blocker binding to bitter receptor hTAS2R39.

Authors:  Wibke S U Roland; Marijn P A Sanders; Leo van Buren; Robin J Gouka; Harry Gruppen; Jean-Paul Vincken; Tina Ritschel
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

7.  Identification of Histamine H3 Receptor Ligands Using a New Crystal Structure Fragment-based Method.

Authors:  Ida Osborn Frandsen; Michael W Boesgaard; Kimberley Fidom; Alexander S Hauser; Vignir Isberg; Hans Bräuner-Osborne; Petrine Wellendorph; David E Gloriam
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

Review 8.  An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.

Authors:  Arun Bahadur Gurung; Mohammad Ajmal Ali; Joongku Lee; Mohammad Abul Farah; Khalid Mashay Al-Anazi
Journal:  Biomed Res Int       Date:  2021-06-24       Impact factor: 3.411

9.  GPCRDB: an information system for G protein-coupled receptors.

Authors:  Vignir Isberg; Bas Vroling; Rob van der Kant; Kang Li; Gert Vriend; David Gloriam
Journal:  Nucleic Acids Res       Date:  2013-12-03       Impact factor: 16.971

10.  A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds--an application for 5-HT1A receptor ligands.

Authors:  Dawid Warszycki; Stefan Mordalski; Kurt Kristiansen; Rafał Kafel; Ingebrigt Sylte; Zdzisław Chilmonczyk; Andrzej J Bojarski
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.